Evidence map›Paper›PMID 39452217›Full record

ArticleAntibiotics (Basel, Switzerland)2024

Genotypic Characterisation and Antimicrobial Resistance of Extended-Spectrum β-Lactamase-Producing

Maisa Kasanga, Márió Gajdács, Walter Muleya, Odion O Ikhimiukor, Steward Mudenda, Maika Kasanga, Joseph Chizimu, Doreen Mainza Shempela, Benjamin Bisesa Solochi, Mark John Mwikisa and 5 more

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. One Health, One Microbiome.Microbiome · 2025
    Review
  7. Article
  8. Article
  9. Emergence of aInfection and drug resistance · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Maisa KasangaDepartment of Pathology and Microbiology, University Teaching Hospitals, Lusaka 15101, Zambia.ORCID 0000-0003-1724-7934
Márió GajdácsDepartment of Oral Biology and Experimental Dental Research, Faculty of Dentistry, University of Szeged, 6720 Szeged, Hungary.ORCID 0000-0003-1270-0365
Walter MuleyaDepartment of Biomedical Sciences, School of Veterinary Medicine, University of Zambia, Lusaka 10101, Zambia.
Odion O IkhimiukorDepartment of Biological Sciences, State University of New York, Albany, NY 12222, USA.ORCID 0000-0002-3738-4584
Steward MudendaDepartment of Pharmacy, School of Health Sciences, University of Zambia, Lusaka 15101, Zambia.ORCID 0000-0003-1692-8981
Maika KasangaDepartment of Pharmacy, University Teaching Hospitals, Lusaka 15101, Zambia.
Joseph ChizimuZambia National Public Health Institute, Ministry of Health, Lusaka 10101, Zambia.
Doreen Mainza ShempelaDepartment of Laboratory Services and Research, Churches Health Association of Zambia, Lusaka 10101, Zambia.ORCID 0009-0003-4945-6746
Benjamin Bisesa SolochiDepartment of Pathology and Microbiology, University Teaching Hospitals, Lusaka 15101, Zambia.
Mark John MwikisaDepartment of Pathology, Lusaka Trust Hospital, Lusaka 10101, Zambia.
Kaunda YambaZambia National Public Health Institute, Ministry of Health, Lusaka 10101, Zambia.
Cheryl P AndamDepartment of Biological Sciences, State University of New York, Albany, NY 12222, USA.ORCID 0000-0003-4428-0924
Raphael ChandaDepartment of Pathology and Microbiology, University Teaching Hospitals, Lusaka 15101, Zambia.
Duncan ChandaCentre of Excellence for Adult Infectious Diseases, University Teaching Hospitals, Lusaka 15101, Zambia.ORCID 0000-0001-5477-9054
Geoffrey KwendaDepartment of Biomedical Sciences, School of Health Sciences, University of Zambia, Lusaka 15101, Zambia.ORCID 0000-0003-0151-8883

Funding

European Union Horizon 2020 research and innovation programme/Trials of Excellence in Southern Africa (EDCTP2/TESA III), Key Project of TESA III (CSA2020NOE3104) and " (CSA2020NOE3104)
6 · The paper itself

Abstract

backgroundExtended-spectrum β-lactamases (ESBL) in

objectiveThis study aimed to identify ESBL-carrying

methodsThis cross-sectional study included 58 ESBL-producing

resultsAmong the strains isolated strains, phylogroup B2 was the most common, with resistant MLST sequence types including ST131, ST167, ST156, and ST69. ESBL genes such as

conclusionsThis study underscores the public health risks of

Indexed as

antimicrobial resistanceESBLEscherichia coliwhole-genome sequencingZambia

Identifiers

PMID39452217
PMCPMC11505244

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.